BioSpace News Archive

Business

Colorectal Surgeon Specializing In Minimally Invasive Procedures Joins Capital Health

Dr. Ashlee Godshalk Ruggles, a board certified, fellowship trained colorectal surgeon with expertise in minimally invasive procedures, recently joined Capital Health Surgical Group

December 4, 2019
·
2 min read
Business

Benchling Joins the AWS Partner Network Global Startups Program

Benchling selected for meeting criteria and providing demonstrated market fit for AWS customers

December 4, 2019
·
3 min read
BioMidwest

Baxter to Present at the 38th Annual J.P. Morgan Healthcare Conference

José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 13, 2020 at 10:00 a.m. Pacific Time.

December 4, 2019
·
1 min read
Deals

Millendo Therapeutics Announces Proposed Public Offering of Common Stock

Millendo Therapeutics, Inc., a late-stage biopharmaceutical company developing novel treatments primarily for orphan endocrine diseases, announced that it has commenced an underwritten public offering of shares of its common stock.

December 4, 2019
·
5 min read
Biotech Bay

Veeva to Present at the Barclays 2019 Global Technology, Media & Telecommunications Conference

The presentation will be webcast. Links to the live and archived webcast will be available on Veeva’s investor relations website at ir.veeva.com

December 4, 2019
·
1 min read
Genetown

Charles River Laboratories Updates Tumor Model Compendium

Update adds over 100 new tumor models and 150 new bioinformatic data sets, increasing translational power of the Compendium

December 4, 2019
·
4 min read
Titan Medical Confirms Receipt of Deficiency Notices From Nasdaq

Nasdaq Rule 5550(a)(2) requires the Shares to maintain a minimum bid price of US$1.00 per Share, and Nasdaq Rule 5810(c)(3)(A) provides that failure to meet such a requirement exists when the bid price of the Shares is below US$1.00 for a period of 30 consecutive business days.

December 4, 2019
·
5 min read
BioCapital

Monumental Treatment Breakthrough for Lupus Kidney Disease

Trial of Voclosporin Meets All Primary and Secondary Endpoints with Clean Safety Profile

December 4, 2019
·
3 min read
First UK Clinical Trial Site Open for Recruitment of Diabetic Patients with Chronic Limb-Threatening Ischemia Using Novel Patient-Specific Regenerative Cell Therapy

The first UK clinical trial site for the treatment of diabetic patients with chronic limb-threatening ischemia (CLI) using a novel patient-specific regenerative therapy has opened for patient recruitment at the University Hospital of Wales in Cardiff

December 4, 2019
·
7 min read
BioMidwest

Tetra Therapeutics Announces Presentation of Data from Retrospective Population-Based Study of 56 Million Patients at the 12th Clinical Trials on Alzheimer’s Disease Meeting (CTAD)

Study Shows that TNF Blocking Agents Reduce Risk of Alzheimer’s Disease in Patients with Rheumatoid Arthritis or Psoriasis

December 4, 2019
·
5 min read